Search Glossary

Name

Abarelix

This definition applies to

All SEER websites where this term appears

Definition

Abarelix, sold under the brand name Plenaxis, is an injectable gonadotropin-releasing hormone antagonist (GnRH antagonist) which is marketed in Germany and the Netherlands. It is primarily used in oncology to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available.

Resource

Title: National Cancer Institute
NCI Dictionary of Cancer Terms

Alternate Names

Plenaxis

Abstractor Notes

See SEER*Rx for information on how to code this drug (http://seer.cancer.gov/seertools/seerrx/)

Histology

None

Primary Sites

None
Glossary